| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in polycythemia vera and lessons for acute leukemia
|
Spivak, Jerry L.
|
|
|
34 |
4 |
p.
|
artikel
|
| 2 |
Can molecular insights guide treatment of AML evolved from MPNs?
|
Crispino, John
|
|
|
34 |
4 |
p.
|
artikel
|
| 3 |
Can venetoclax-based therapy replace 7+3 induction in fit older adults with AML?
|
Foran, James M.
|
|
|
34 |
4 |
p.
|
artikel
|
| 4 |
Changing trends in the therapy of acute myeloid leukemia
|
Rowe, Jacob M.
|
|
|
34 |
4 |
p.
|
artikel
|
| 5 |
Current status of pretransplant intensive chemotherapy or hypomethylating agents for myelodysplastic syndrome
|
Niederwieser, Christian
|
|
|
34 |
4 |
p.
|
artikel
|
| 6 |
Editorial Board / Aims & Scope
|
|
|
|
34 |
4 |
p.
|
artikel
|
| 7 |
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia
|
Appelbaum, Frederick R.
|
|
|
34 |
4 |
p.
|
artikel
|
| 8 |
Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?
|
Tran, Thai Hoa
|
|
|
34 |
4 |
p.
|
artikel
|
| 9 |
How do molecular aberrations guide therapy in MDS?
|
Bejar, Rafael
|
|
|
34 |
4 |
p.
|
artikel
|
| 10 |
How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
|
Steensma, David P.
|
|
|
34 |
4 |
p.
|
artikel
|
| 11 |
Important factors improving outcome of young adults with acute lymphoblastic leukemia (ALL)
|
Bleyer, Archie
|
|
|
34 |
4 |
p.
|
artikel
|
| 12 |
Is the current consolidation regimen for AML evidence-based?
|
Luger, Selina M.
|
|
|
34 |
4 |
p.
|
artikel
|
| 13 |
Is there an optimal adjunct therapy to traditional cytotoxic induction?
|
Michaelis, Laura C.
|
|
|
34 |
4 |
p.
|
artikel
|
| 14 |
It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in high-risk MDS
|
Aguirre, Luis E.
|
|
|
34 |
4 |
p.
|
artikel
|
| 15 |
Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage
|
Montefiori, Lindsey E.
|
|
|
34 |
4 |
p.
|
artikel
|
| 16 |
Since everyone has a donor, why are some eligible patients still not transplanted?
|
Eapen, Mary
|
|
|
34 |
4 |
p.
|
artikel
|
| 17 |
What is the role of the bone marrow microenvironment in AML?
|
Mulherkar, Nirupama
|
|
|
34 |
4 |
p.
|
artikel
|
| 18 |
Will immunotherapy lead to a breakthrough in the treatment of older adults with ALL?
|
Aldoss, Ibrahim
|
|
|
34 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving